Ionis Pharmaceuticals (IONS) Operating Margin Growth (3y) (2012 - 2026)

Ionis Pharmaceuticals (IONS) Operating Margin Growth (3y) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (3y) (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 9,942.00
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 530.00
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -1,211.00
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -623.00
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 Ionis Pharmaceuticals 9.27 Bn 7.36 Bn 243.11 Mn 3,974.00

Historic Data

Download Data
DateValue
Mar 31, 2026 3,974.00
Dec 31, 2025 3,148.00
Sep 30, 2025 -6,518.00
Jun 30, 2025 705,472.00
Mar 31, 2025 -7,107.00
Dec 31, 2024 -9,905.00
Sep 30, 2024 -4,659.00
Jun 30, 2024 2,869.00
Mar 31, 2024 -4,271.00
Dec 31, 2023 5,312.00
Sep 30, 2023 -7,652.00
Jun 30, 2023 35,024.00
Mar 31, 2023 -4,162.00
Dec 31, 2022 -71,618.00
Sep 30, 2022 -4,712.00
Jun 30, 2022 24,987.00
Mar 31, 2022 -12,154.00
Dec 31, 2021 -1,148.00
Sep 30, 2021 12,122.00
Jun 30, 2021 -1,532.00